Clinical trial
A Randomized, Placebo-controlled, Double-blind, Multi-center, Phase 2 Study to Assess the Efficacy and Safety of CNTO 6785 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
The change from baseline in pre-bronchodilator FEV1 at Week 16
| Category | Value |
|---|---|
| Study start date | 2013-07-26 |